Article metrics
PDF
Other content recommended for you
- Phase 1 oncology trials and informed consent
- Unrealistic optimism and the ethics of phase I cancer research
- Two concepts of therapeutic optimism
- Understanding people’s ‘unrealistic optimism’ about clinical research participation
- Perceptions of control and unrealistic optimism in early-phase cancer trials
- Therapeutic appropriation: a new concept in the ethics of clinical research
- From protection to entitlement: selecting research subjects for early phase clinical trials involving breakthrough therapies
- Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial
- Vulnerability, therapeutic misconception and informed consent: is there a need for special treatment of pregnant women in fetus-regarding clinical trials?
- Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study